Functional echocardiography in staging for ductal disease severityRole in predicting outcomes

被引:0
作者
Arvind Sehgal
Eldho Paul
Samuel Menahem
机构
[1] Monash Medical Centre,Monash Newborn
[2] Monash University,Department of Pediatrics
[3] Monash University,School of Public Health and Preventive Medicine
[4] MonashHeart,undefined
[5] Southern Health,undefined
来源
European Journal of Pediatrics | 2013年 / 172卷
关键词
Echocardiography; Staging; Ductus arteriosus; Chronic lung disease;
D O I
暂无
中图分类号
学科分类号
摘要
Equipoise persists as to the issue of assigning haemodynamic and clinical significance to a patent ductus arteriosus (PDA). The objective was to ascertain whether echocardiographic scoring of a PDA correlates with outcomes. Unit electronic data base was accessed to identify infants less than 32 weeks’ gestation who received ibuprofen for medical closure of the PDA during the period June 2010–June 2012. Echocardiographic score was assigned on the day of therapy and the infants were prospectively followed up to ascertain the occurrence of chronic lung disease (CLD). Logistic regression analysis was used to estimate the association between composite score and occurrence of CLD. Fifty-two infants were identified out of which 27 (52 %) subsequently developed CLD. Echocardiographic parameters were of a significantly higher magnitude in infants who later developed CLD. The median composite score (inter-quartile range) was also significantly higher in this group 26 (24–26) vs. 19 (17–20), p < 0.001). Higher composite scores were associated with increased risk of developing CLD; for every one point increase in composite score, the odds of CLD increased by 78 % (odds ratio (95 % CI): 1.78 (1.35–2.34); p < 0.001). Conclusions: Infants with a high composite score, assigned according to the staging criteria at the time of treatment, were noted to have a higher incidence of subsequent CLD. Whether disease stratification can be the basis of further RCT’s needs prospective evaluation.
引用
收藏
页码:179 / 184
页数:5
相关论文
共 74 条
[1]  
Benitz WE(2010)Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 30 241-252
[2]  
Bose CL(2007)Patent ductus arteriosus: lack of evidence for common treatments Arch Dis Child Fetal Neonatal Ed 92 F498-F502
[3]  
Laughon MM(2009)Duration of indomethacin treatment of the preterm patent ductus arteriosus as directed by echocardiography J Pediatr 155 819.e1-822.e1
[4]  
Carmo KB(2005)Severity of the ductal shunt: a comparison of different markers Arch Dis Child Fetal Neonatal Ed 90 F419-F422
[5]  
Evans N(2011)Troponin T, N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants Arch Dis Child Fetal Neonatal Ed 96 F133-F137
[6]  
Paradisis M(1995)Longitudinal changes in the diameter of the ductus arteriosus in ventilated preterm infants: correlation with respiratory outcomes Arch Dis Child Fetal Neonatal Ed 72 F156-F161
[7]  
El Hajjar M(1993)Diagnosis of patent ductus arteriosus in the preterm newborn Arch Dis Child 68 58-61
[8]  
Vaksmann G(2003)Current controversies in the diagnosis and treatment of patent ductus arteriosus in preterm infants Adv Neonatal Care 3 168-177
[9]  
Rakza T(2011)Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention acta Paediatr 100 231-235
[10]  
Kongolo G(1987)Noninvasive Doppler echocardiographic evaluation of shunt flow haemodynamics of the ductus arteriosus Circulation 75 1146-1153